<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01489852</url>
  </required_header>
  <id_info>
    <org_study_id>E2PRETREATMENT</org_study_id>
    <nct_id>NCT01489852</nct_id>
  </id_info>
  <brief_title>Estrogen Pretreatment Prior to GnRH Antagonist Protocol</brief_title>
  <official_title>Interest of a Steroid Pre-treatment Prior to IVF Protocol With Ovarian Stimulation by Recombinant FSH and With LH Surge Blockage by Daily GnRH Antagonist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gemer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gemer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether estrogen pre-treatment can allow retrieval of
      2 additional oocytes in GnRH antagonist protocol.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of retrieved oocytes</measure>
    <time_frame>at the ovarian puncture, 36 hours post HCG administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>at pregnancy test and at 6 Week US examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>delivery rate</measure>
    <time_frame>9 months later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of obtained embryos</measure>
    <time_frame>2 days after in vitro fertilization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of FSH administration</measure>
    <time_frame>at the end of ovarian stimulation usually after a mean of 12 days of administration</time_frame>
    <description>number of days of administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total FSH dose</measure>
    <time_frame>at the end of ovarian stimulation usually after a mean of 12 days of administration</time_frame>
    <description>daily dose x number of days of administration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">472</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Estrogen pre-treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group did not receive any pre-treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>17beta-estradiol</intervention_name>
    <description>Pretreatment with 17beta-estradiol (Provames®, Aventis, Paris, France) was administered daily (2 mg twice a day) during the cycle preceding the IVF/ICSI cycle, starting 7 days before the predicted onset of menses and administered up until to the following Thursday after the occurrence of menses.</description>
    <arm_group_label>Estrogen pre-treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  regular normo-ovulatory cycles (28 to 35 days)

          -  age &lt; 38 years,

          -  body mass index (BMI) between 18 and 30

          -  first or second IVF/ICSI attempt

        Exclusion Criteria:

          -  high basal levels of serum FSH or E2,

          -  less than 5 follicles at the antral follicular count performed on day 3 of a
             spontaneous cycle,

          -  history of high (&gt;20 oocytes) or low (&lt; 5 oocytes) ovarian response in a previous IVF
             attempt
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Noel Hugues, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpital Jean Verdier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle cedrin-durnerin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Jean Verdier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Medecine de la Reproduction, Hôpital Jean Verdier</name>
      <address>
        <city>Bondy</city>
        <state>Ile de France</state>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2011</study_first_submitted>
  <study_first_submitted_qc>December 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2011</study_first_posted>
  <last_update_submitted>December 9, 2011</last_update_submitted>
  <last_update_submitted_qc>December 9, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gemer</investigator_affiliation>
    <investigator_full_name>Dr CEDRIN-DURNERIN Isabelle</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>Assisted reproductive treatment</keyword>
  <keyword>GnRH antagonist</keyword>
  <keyword>Estrogen pre-treatment</keyword>
  <keyword>Ovarian stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estradiol</mesh_term>
    <mesh_term>Polyestradiol phosphate</mesh_term>
    <mesh_term>Estrogens</mesh_term>
    <mesh_term>Estradiol 3-benzoate</mesh_term>
    <mesh_term>Estradiol 17 beta-cypionate</mesh_term>
    <mesh_term>Estradiol valerate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

